Back

Pfizer hits 52-week peak after strong second-quarter 2026 results

Verifying
  • Pfizer shares reached a new 52-week peak during Tuesday’s trading session.
  • $29.09 was the intraday high, while shares closed at $28.75.
  • Pfizer settled more than 6,000 federal lawsuits involving Depo-Provera allegations.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Pfizer hits 52-week peak after strong second-quarter 2026 results - CoinPost Terminal